In diabetic cardiomyopathy, ceramide synthase 2 (CerS2)- and CerS5-derived ceramides, including VLC ceramides, led to increased mitophagy and insulin resistance (56). This evidence concerns the gene CERS2 and diabetic cardiomyopathy.